Login Register Cart 0
Generic placeholder image

Current Organic Synthesis

Editor-in-Chief

ISSN (Print): 1570-1794
ISSN (Online): 1875-6271

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Research Article

Synthesis, Characterization and Preliminary Screening of New N-Substituted -8-Methyl-4-Hydroxy-2-Quinolone -3-Carboxamides as Potential Anticancer Agents

Author(s): Dania Altaher, Hiba Zalloum, Kamal Sweidan*, Dima A. Sabbah, Husam AlSalamat, Mahmoud Sunjuk and Reem Isleem

Volume 22, Issue 2, 2025

Published on: 17 April, 2024

Page: [270 - 279] Pages: 10

DOI: 10.2174/0115701794291133240327044308

Price: $65

TIMBC 2025
Abstract

Introduction: A new series of 4-hydroxy-8-methyl-2-oxo-1,2-dihydroquinoline-3- carboxamide derivatives has been synthesized in good yields, followed by complete characterization using 1D-NMR, 2D-NMR, and IR techniques.

Methods: The final products contain amide, hydroxyl, and aromatic functional groups that usually show significant bioactivity. The target products have been examined towards three cancer cell lines, namely colorectal cancer cell line (HCT116), breast cancer cell line (MCF-7), and leukemia cell line (K562) in addition to the fibroblast cells, that were used as a model for normal human tissue.

Results: The anticancer results signified that compound 6 showed the most activity in the series accomplished with IC50 values of 14.6, 5.3 and 12.8 µM,

Conclusion: Other compounds exhibited considerable activity, such as compounds 9 (IC50 3.5 and 19.0 µM), 10 (IC50 12.6 µM), and 11 (IC50 10.3 µM) against the three cancer cell lines HCT116, MCF-7 and K562, respectively.

Keywords: Anticancer, quinolone, HCT116, MCF-7, K562, N-Substituted -8-Methyl-4-Hydroxy-2-Quinolone -3-Carboxamides.

« Previous Next »
Graphical Abstract

[1]
Malik, M.A.; Dar, O.A.; Gull, P.; Wani, M.Y.; Hashmi, A.A. Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy. MedChemComm, 2018, 9(3), 409-436.
[http://dx.doi.org/10.1039/C7MD00526A] [PMID: 30108933]
[2]
Khwaza, V.; Mlala, S.; Oyedeji, O.O.; Aderibigbe, B.A. Pentacyclic triterpenoids with nitrogen-containing heterocyclic moiety, privileged hybrids in anticancer drug discovery. Molecules, 2021, 26(9), 2401.
[http://dx.doi.org/10.3390/molecules26092401] [PMID: 33918996]
[3]
Hersi, F.; Omar, H.A.; Al-Qawasmeh, R.A.; Ahmad, Z.; Jaber, A.M.; Zaher, D.M.; Al-Tel, T.H. Design and synthesis of new energy restriction mimetic agents: Potent anti-tumor activities of hybrid motifs of aminothiazoles and coumarins. Sci. Rep., 2020, 10(1), 2893.
[http://dx.doi.org/10.1038/s41598-020-59685-x] [PMID: 32076009]
[4]
Abdel-Sattar, E.; Zaitoon, A.; El Sayed, A.M.; Bakhashwain, A.A. Evaluation of some medicinal plants in controlling Culex pipiens. J. Egypt. Soc. Parasitol., 2014, 44(3), 771-778.
[http://dx.doi.org/10.12816/0007880] [PMID: 25643518]
[5]
Ahsan, H.; Reagan-Shaw, S.; Breur, J.; Ahmad, N. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett., 2007, 249(2), 198-208.
[http://dx.doi.org/10.1016/j.canlet.2006.08.018] [PMID: 17005319]
[6]
Guaman Ortiz, L.M. Multiple effects of berberine derivatives on colon cancer cells. BioMed Res. Int., 2014, 1-12.
[7]
Wall, M.E.; Wani, M.C.; Cook, C.E.; Palmer, K.H.; McPhail, A.T.; Sim, G.A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from camptotheca acuminata1, 2. J. Am. Chem. Soc., 1966, 88(16), 3888-3890.
[http://dx.doi.org/10.1021/ja00968a057]
[8]
Sweidan, K.; Zalloum, H.; Sabbah, D.A.; Idris, G.; Abudosh, K.; Mubarak, M.S. Synthesis, characterization, and anticancer evaluation of some new N 1-(anthraquinon-2-yl) amidrazone derivatives. Can. J. Chem., 2018, 96(12), 1123-1128.
[http://dx.doi.org/10.1139/cjc-2018-0145]
[9]
Ukrainets, I.V.; Mospanova, E.V.; Bereznyakova, N.L.; Davidenko, A.A. Modification of the benzene moiety in the quinolone nucleus of 4-hydroxy-6, 7-dimethoxy-2-oxo-N-(pyridin-3-ylmethyl)-1, 2-dihydroquinoline-3-carboxamide as an attempt to enhance its analgesic activity. Pharm. Chem. J., 2019, 52(10), 825-829.
[http://dx.doi.org/10.1007/s11094-019-1908-8]
[10]
Sabbah, D.A.; Hishmah, B.; Sweidan, K.; Bardaweel, S.; AlDamen, M.; Zhong, H.A.; Abu Khalaf, R.; Hasan Ibrahim, A.; Al-Qirim, T.; Abu Sheikha, G.; Mubarak, M.S. Structure-based design: Synthesis, X-ray crystallography, and biological evaluation of n-substituted-4-hydroxy-2-quinolone-3-carboxamides as potential cytotoxic agents. Anticancer. Agents Med. Chem., 2018, 18(2), 263-276.
[http://dx.doi.org/10.2174/1871520617666170911171152] [PMID: 28901259]
[11]
Keating, G.M. Dasatinib: A review in chronic myeloid leukaemia and ph+ acute lymphoblastic leukaemia. Drugs, 2017, 77(1), 85-96.
[http://dx.doi.org/10.1007/s40265-016-0677-x] [PMID: 28032244]
[12]
Sweidan, K.A.; Sabbah, D.; Engelmann, J.; Abdel-Halim, H.; Abu Sheikha, G. Computational docking studies of novel heterocyclic carboxamides as potential PI3Kα inhibitors. Lett. Drug Des. Discov., 2015, 12(10), 856-863.
[http://dx.doi.org/10.2174/1570180812666150529205248]
[13]
Wermuth, C.G. The Practice of Medicinal Chemistry, 3rd ed; Academic Press: New York, 2011.
[14]
Barreiro, E.J.; Kümmerle, A.E.; Fraga, C.A.M. The methylation effect in medicinal chemistry. Chem. Rev., 2011, 111(9), 5215-5246.
[http://dx.doi.org/10.1021/cr200060g] [PMID: 21631125]
[15]
Sun, S.; Fu, J. Methyl-containing pharmaceuticals: Methylation in drug design. Bioorg. Med. Chem. Lett., 2018, 28(20), 3283-3289.
[http://dx.doi.org/10.1016/j.bmcl.2018.09.016] [PMID: 30243589]
[16]
Pinheiro, P.S.M.; Franco, L.S.; Fraga, C.A.M. The magic methyl and its tricks in drug discovery and development. Pharmaceuticals, 2023, 16(8), 1157.
[http://dx.doi.org/10.3390/ph16081157] [PMID: 37631072]
[17]
Mallah, E.; Sweidan, K.; Engelmann, J.; Steimann, M.; Kuhn, N.; Maier, M.E. Nucleophilic substitution approach towards 1,3-dimethylbarbituric acid derivatives-new synthetic routes and crystal structures. Tetrahedron, 2012, 68(4), 1005-1010.
[http://dx.doi.org/10.1016/j.tet.2011.11.093]
[18]
Sweidan, K.; Abu-Salem, Q.; Al-Sheikh, A.; Sheikha, G. Novel derivatives of 1, 3-dimethyl-5-methylenebarbituric acid. Lett. Org. Chem., 2009, 6(8), 669-672.
[http://dx.doi.org/10.2174/157017809790442934]
[19]
Al-Qawasmeh, R.A.; Huthail, B.B.; Sinnokrot, M.O.; Semreen, M.H.; Odeh, R.A.; Abu-Zarga, M.H.; Tarazi, H.; Yousef, I.A.; Al-Tel, T.H. Design, synthesis and qualitative structure activity relationship evaluations of quinoline-based bisarylimidazoles as antibacterial motifs. Med. Chem., 2016, 12(6), 563-573.
[http://dx.doi.org/10.2174/1573406412666160518142441] [PMID: 27188185]
[20]
Al-Qawasmeh, R.A.; Abadleh, M.M.; Zahra, J.A.; El-Abadelah, M.M.; Albashiti, R.; Zani, F.; Incerti, M.; Vicini, P. Design synthesis and antibacterial activity studies of new thiadiazoloquinolone compounds. J. Enzyme Inhib. Med. Chem., 2014, 29(6), 777-785.
[http://dx.doi.org/10.3109/14756366.2013.855925] [PMID: 24506209]
[21]
Sweidan, K.; Sabbah, D.A.; Bardaweel, S.; Abu Sheikha, G.; Al-Qirim, T.; Salih, H.; El-Abadelah, M.M.; Mubarak, M.S.; Voelter, W. Facile synthesis, characterization, and cytotoxicity study of new 3-(indol-2-yl)bicyclotetrazatridecahexaens. Can. J. Chem., 2017, 95(8), 858-862.
[http://dx.doi.org/10.1139/cjc-2017-0120]
[22]
Sabbah, D.A.; Haroon, R.A.; Bardaweel, S.K.; Hajjo, R.; Sweidan, K. N-phenyl-6-chloro-4-hydroxy-2-quinolone-3-carboxamides: Molecular docking, synthesis, and biological investigation as anticancer agents. Molecules, 2020, 26(1), 73.
[http://dx.doi.org/10.3390/molecules26010073] [PMID: 33375766]
[23]
Sabbah, D.A.; Hasan, S.E.; Abu Khalaf, R.; Bardaweel, S.K.; Hajjo, R.; Alqaisi, K.M.; Sweidan, K.A.; Al-Zuheiri, A.M. Molecular modeling, synthesis and biological evaluation of N-phenyl-4-hydroxy-6-methyl-2-quinolone-3-carboxamides as anticancer agents. Molecules, 2020, 25(22), 5348.
[http://dx.doi.org/10.3390/molecules25225348] [PMID: 33207767]

Rights & Permissions Print Cite
Article Metrics
8
1
Wayfinder Image
TIMBC 2025
© 2025 Bentham Science Publishers | Privacy Policy